Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00208702Phase 4Completed
Phase 4, randomised trial in major depressive disorder (MDD) comparing sertraline + triiodothyronine with sertraline + placebo (2 arms). Primary endpoint: Montgomery-Åsberg Depression Rating Scale. Started Sep 1996; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00208702.